GRI vs TAP · P/E 0.1, $3.5M cap vs rev $13.04B
GRI Bio Inc. (GRI) versus TAP (TAP) — a side-by-side from cached financials, not a winner call.
GRI Bio Inc. (GRI) is a biotechnology company listed on US.
TAP (TAP) common stock.
GRI does not have a complete income-statement cache yet.
Latest reported TAP revenue for 2025-12-31 was $13.04B. Net income was -$2.14B. Revenue was down 5.1% from 2024-12-31 to 2025-12-31. TAP currently screens at market cap $0.
GRI currently screens at market cap $3.5M and trailing P/E 0.1. TAP currently screens at market cap $0.
Not investment advice. Open the GRI and TAP stock pages for the full models.
Not investment advice.